Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Amendment To The License AgreementLicense Agreement • March 11th, 2009 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
This Amendment, effective the 12th day of February, 2009, (“Amendment Date”) is by and between Idera Pharmaceuticals, Inc., having a place of business located at 167 Sidney Street, Cambridge, Massachusetts 02139 (“Idera”) and Merck KGaA, a general partnership limited by shares organized under German law having a place of business at Frankfurter Strasse 250, 64293 Darmstadt, Germany (“Merck”). Idera and Merck may be referred to collectively as “Parties.”
AMENDMENT TO THE CONSULTING SERVICES AGREEMENTThe Consulting Services Agreement • March 11th, 2009 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
This Amendment, effective the 16th day of December, 2008, (“Amendment Date”) is by and between Idera Pharmaceuticals, Inc., a Delaware corporation, having an place of business at 167 Sidney Street, Cambridge, Massachusetts 02139 (hereinafter referred to as “Idera”) and Karr Pharma Consulting, LLC, having a place of business at 707 Dominion Drive, St. Louis, Missouri 63131 (hereinafter referred to as the “Consultant”). Idera and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties.”
